Приказ основних података о документу

dc.creatorLjujić, Mila
dc.creatorMijatović, Sanja
dc.creatorBulatović, Mirna Z.
dc.creatorMojic, Marija
dc.creatorMaksimović-Ivanić, Danijela
dc.creatorRadojković, Dragica
dc.creatorTopić, Aleksandra
dc.date.accessioned2019-09-02T12:01:33Z
dc.date.available2019-09-02T12:01:33Z
dc.date.issued2017
dc.identifier.issn1219-4956
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2964
dc.description.abstractIncreased circulating alpha-1-antitrypsin (AAT) correlates with cancer stage/aggressiveness, but its role in cancer biology is unclear. We revealed antagonistic effect of AAT to cisplatin-induced cytotoxicity in prostate (PC3) and melanoma (A375) cancer cell lines. Moreover, AAT abrogated cytotoxicity of MEK inhibitor U0126 in PC3 cell line. Weaker antagonistic effect of AAT on cytotoxicity of PI3/Akt and NF-kB inhibitors was also observed. In addition, cisplatin increased AAT gene expression in transfected PC3 cells. However, AAT derived from transfected PC3 cells did not antagonize cisplatin-induced cytotoxicity. In conclusion, these results suggest possible association between high circulating AAT and cisplatin resistance.en
dc.publisherSpringer, Dordrecht
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173013/RS//
dc.rightsrestrictedAccess
dc.sourcePathology & Oncology Research
dc.titleAlpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Linesen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЉујић, Мила; Максимовић-Иванић, Данијела; Радојковић, Драгица; Мојиц, Марија; Топиц, Aлександра; Булатовић, Мирна З.; Мијатовић, Сања;
dc.citation.volume23
dc.citation.issue2
dc.citation.spage335
dc.citation.epage343
dc.citation.other23(2): 335-343
dc.citation.rankM22
dc.identifier.wos000399000200014
dc.identifier.doi10.1007/s12253-016-0104-3
dc.identifier.pmid27617337
dc.identifier.scopus2-s2.0-85016626907
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу